Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate Cancers [Phase 2]
Phase 2 trial update evaluating surgery combined with intensity-modulated radiation therapy with image guidance in locally-advanced prostate…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer [Phase 2]
Phase 2 clinical trial updating the use of everolimus in newly diagnosed localized prostate cancer; study terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Cabozantinib in Men With Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial investigating cabozantinib in men with castration-resistant prostate cancer has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-27Clinical Trial Update: Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating hormonal therapy and chemotherapy followed by prostatectomy in prostate cancer; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer [Phase 2]
Phase 2 trial evaluating PROSTVAC/TRICOM vaccine therapy with flutamide versus flutamide alone for prostate cancer completed with posted res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects [NA]
Pilot study assessing safety and efficacy of BioProtect Balloon in prostate cancer subjects has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer [Phase 1]
Phase 1 trial update for TAK-385 in hormone treatment-naïve prostate cancer participants; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Lung Protective Ventilation During Robotic Assisted Prostatectomy [Phase 3]
Phase 3 clinical trial evaluating lung protective ventilation during robotic-assisted prostatectomy has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer [Phase 2]
Phase 2 trial evaluating preoperative thalidomide followed by radical retropubic prostatectomy in select patients with locally advanced pros…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer [Phase 2]
Phase II trial update for DCVAC/PCa following primary radiotherapy in high-risk localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement [Phase 3]
Phase 3 trial evaluating zoledronic acid for bone involvement in metastatic breast cancer, metastatic prostate cancer, or multiple myeloma; …
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer [Phase 2]
Phase 2 trial assessing bortezomib with or without hormone therapy in relapsed prostate cancer; trial terminated with results posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: A Study of Olaratumab (IMC-3G3) in Prostate Cancer [Phase 2]
Phase 2 clinical trial update for olaratumab (IMC-3G3) in prostate cancer has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neoadjuvant androgen ablation with cyclophosphamide and GVAX vaccine in localized prostate cancer (Phase 1 and Ph…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer [Phase 3]
Phase 3 trial comparing chemotherapy plus hormone therapy versus androgen suppression in metastatic or unresectable prostate cancer has comp…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma [Phase 1, Phase 2]
Clinical trial evaluating paclitaxel, estramustine phosphate, and thalidomide in metastatic androgen-independent prostate cancer (Phase 1/2)…
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Vidaza to Restore Hormone Thx Prostate [Phase 2]
Phase 2 trial update for Vidaza in prostate cancer with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer [NA]
A completed clinical trial evaluating MRI-guided transurethral ultrasound ablation for localized prostate cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer [Phase 2]
Phase 2 trial update exploring reduced toxicity with focal brachytherapy in early-stage, low-volume prostate cancer; study terminated with r…
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone [Phase 2]
Phase 2 trial update for OGX-427 in metastatic castration-resistant prostate cancer with PSA progression on abiraterone; study status termin…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T [Phase 2]
Phase 2 efficacy trial evaluating implantation of mouse renal adenocarcinoma macrobeads in men with castration-resistant prostate cancer tha…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: AMG 386 and Abiraterone for Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial update for AMG 386 combined with Abiraterone in advanced prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Safety Study of a Shorter (Hypofractionated) Radiotherapy for the Prostate Bed With or Without the Pelvic Lymph Nodes [Phase 2]
Phase 2 safety study update evaluating hypofractionated radiotherapy to the prostate bed with or without pelvic lymph nodes in prostate canc…
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) [Phase 3]
A Phase 3 trial evaluating Abiraterone acetate plus low-dose prednisone and androgen deprivation therapy versus ADT alone in newly diagnosed…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy [Phase 2]
Phase 2 clinical trial update evaluating vaccine plus booster shots in men with prostate cancer undergoing radical prostatectomy.